This website contains information about research peptides intended exclusively for licensed researchers and qualified professionals.
DISCLAIMER: Products sold for legitimate research purposes only. Not approved for human use.
Detailed educational profiles on each compound in our catalog. Third-party tested and independently verified for purity, potency, and identity.
Body Protection Compound 157 — a 15-amino acid synthetic peptide derived from a human gastric juice protein. One of the most extensively studied peptides in preclinical research for tissue repair and regeneration.
⚠️ Research Note: All data on BPC-157 is derived from preclinical (animal) studies. BPC-157 is not FDA-approved for human use. This compound is sold exclusively for in vitro and in vivo research by qualified professionals.
TB-500 is a synthetic analogue of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid peptide found in virtually all nucleated cells. It plays a central role in actin sequestration, cell migration, and tissue repair processes.
⚠️ Research Note: TB-500 is not approved by any regulatory authority for human therapeutic use. All available data is derived from in vitro studies and animal models. Intended for research by licensed professionals only.
A synergistic two-peptide research stack. CJC-1295 is a long-acting GHRH analogue; Ipamorelin is a highly selective GH secretagogue. Combined, they target complementary receptors in the hypothalamic-pituitary axis for maximal GH pulse research.
⚠️ Research Note: Neither CJC-1295 nor Ipamorelin is FDA-approved. All compounds are for in vitro/in vivo research only by licensed professionals. Not for human consumption.
Retatrutide (LY3437943) is a novel triple agonist peptide with activity at the GIP (glucose-dependent insulinotropic polypeptide), GLP-1, and glucagon receptors simultaneously — making it one of the most advanced metabolic research compounds currently under investigation.
⚠️ Research Note: Retatrutide is an investigational compound currently in clinical trials by Eli Lilly & Co. (Phase 3). Our supply is for preclinical research purposes only by licensed researchers. Not for human use.
All compounds are independently verified, research-grade, and available to licensed researchers upon credential review.
A small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Research suggests it may influence NAD+ metabolism, adipogenesis, and energy expenditure in preclinical models.
Delta Sleep-Inducing Peptide — a nonapeptide studied for its effects on sleep architecture, stress response modulation, and neuroendocrine regulation in animal models.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland epithalamin. Studied for its role in telomerase activation, antioxidant activity, and circadian regulation.
A bioregulatory peptide researched for its potential role in musculoskeletal recovery, inflammation modulation, and tissue repair signaling in preclinical settings.
A bioregulatory peptide studied in the context of cellular repair, oxidative stress reduction, and tissue homeostasis. Researched alongside KLOW in recovery-focused protocols.
A tripeptide (Glu-Cys-Gly) and the body's master antioxidant. Studied extensively for its role in oxidative stress neutralization, immune modulation, and detoxification pathways.
A selective growth hormone secretagogue and ghrelin receptor agonist. Studied for its clean GH release profile with minimal effect on cortisol or prolactin in animal models.
A C-terminal tripeptide of alpha-MSH (Lys-Pro-Val) with potent anti-inflammatory properties. Researched for gut inflammation, wound healing, and immune regulation in preclinical models.
The only member of the human cathelicidin family of antimicrobial peptides. Studied for broad-spectrum antimicrobial activity, immune modulation, and wound repair in research settings.
A mitochondria-derived peptide encoded in mitochondrial DNA. Studied for its role in metabolic homeostasis, insulin sensitivity, exercise response, and longevity signaling.
A linear synthetic analogue of alpha-MSH that binds non-selectively to melanocortin receptors. Studied primarily for pigmentation research and UV protection mechanisms in preclinical models.
A cyclic synthetic analogue of alpha-MSH with higher receptor affinity. Researched for melanogenesis, sexual function pathways, and appetite regulation via melanocortin receptor subtypes.
Nicotinamide Adenine Dinucleotide — a critical coenzyme in cellular energy metabolism. Studied for its role in DNA repair, sirtuin activation, mitochondrial function, and aging biology.
A synthetic heptapeptide analogue of tuftsin developed in Russia. Studied for anxiolytic-like effects, cognitive enhancement, and immune modulation in animal research models.
Bremelanotide — a cyclic peptide derived from Melanotan 2 acting on MC3R and MC4R receptors. Studied for sexual dysfunction research and centrally mediated arousal pathway modulation.
A small molecule ERR (estrogen-related receptor) agonist studied for its ability to mimic exercise-induced metabolic adaptations, including mitochondrial biogenesis and fat oxidation.
A synthetic analogue of GHRH (growth hormone-releasing hormone) comprising its first 29 amino acids. Studied for stimulating endogenous GH release via the pituitary in preclinical models.
A stabilized synthetic GHRH analogue studied for visceral adipose tissue reduction, GH axis modulation, and lipodystrophy-related research in preclinical and clinical settings.
A 28-amino acid peptide derived from thymosin fraction 5. Extensively studied for immune modulation, T-cell differentiation, and antiviral / antitumor activity in preclinical and clinical research.
Methylcobalamin / Cyanocobalamin — an essential water-soluble vitamin and enzyme cofactor. Studied for neurological function, red blood cell formation, homocysteine regulation, and DNA synthesis.
Copper peptide GHK-Cu (Gly-His-Lys) is a naturally occurring human plasma peptide with strong affinity for copper ions. Studied for tissue remodeling, anti-inflammatory activity, and wound repair.